News

August 2017

New study: Chondroitin comparable to celecoxib for osteoarthritis

New clinical research shows that chondroitin sulfate 800 mg once daily is comparable to celecoxib 200 mg daily for reducing pain in patients with knee osteoarthritis.  For patients who want to try it, explain that the best evidence is for higher-quality, pharmaceutical-grade products. Some of these products include Chondrosulf (IBSA Institut Biochimique SA), Chondrosan (Bioibérica, S.A.), and Structrum (Pierre Fabre Medicament). Studies using these products have more consistently shown benefit. Also, keep in mind that chondroitin is not fast acting - it can take several weeks before there is significant benefit.  Patients might also need analgesics for acute pain flare ups while taking chondroitin. 

For more details on chondroitin sulfate for treating osteoarthritis, review our scientific monograph.

The information in this brief report is intended for informational purposes only, and is meant to help users better understand health concerns. This information should not be interpreted as specific medical advice. Users should consult with a qualified healthcare provider for specific questions regarding therapies, diagnosis and/or health conditions, prior to making therapeutic decisions. Copyright © 2024 NatMed. Commercial distribution or reproduction prohibited. NatMed is the leading provider of high-quality, evidence-based, clinically-relevant information on natural medicine, dietary supplements, herbs, vitamins, minerals, functional foods, diets, complementary practices, CAM modalities, exercises and medical conditions. Monograph sections include interactions with herbs, drugs, foods and labs, contraindications, depletions, dosing, toxicology, adverse effects, pregnancy and lactation data, synonyms, safety and effectiveness.